LGI4 Antibodies

Santa Cruz Biotechnology provides a broad selection of LGI4 monoclonal antibodies for research focused on understanding LGI4's role in various biological processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LGI4, or Leucine-rich glioma-inactivated 4, is a protein that plays a crucial role in neuronal development and synaptic function. LGI4 is involved in the modulation of synaptic transmission and has been linked to various neurological disorders. Research has shown that LGI4 influences myelination in the peripheral nervous system. Studies indicate that mutations in LGI4 can lead to developmental abnormalities in nerve function. Understanding LGI4's molecular mechanisms provides valuable insights into potential therapeutic approaches for neurological conditions. Investigating LGI4's expression patterns helps reveal its distribution across different neural tissues. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance our understanding of LGI4's role in neuroscience and contribute to potential therapeutic breakthroughs.